CGTX Historical PE Ratio image   This CGTX PE ratio history page last updated 4/23/2024
CGTX PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/26/2024
1.83-0.27-0.86NA
Q3 2023
11/2/2023
1.02-0.22-0.79NA
Q2 2023
8/8/2023
1.72-0.16-0.86NA
Q1 2023
5/4/2023
1.67-0.21-0.95NA
Q4 2022
3/23/2023
1.83-0.20-0.91NA
Q3 2022
11/14/2022
1.24-0.29-12.45NA
Q2 2022
8/9/2022
2.64-0.25-20.28NA
Q1 2022
5/11/2022
2.50-0.17NANA
Q4 2021
3/30/2022
2.66-11.74NANA
Q3 2021
11/18/2021
10.71-8.12NANA
CGTX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/26/2024
1.83-0.27-1.08NA
Q3 2023
11/2/2023
1.02-0.22-0.88NA
Q2 2023
8/8/2023
1.72-0.16-0.64NA
Q1 2023
5/4/2023
1.67-0.21-0.84NA
Q4 2022
3/23/2023
1.83-0.20-0.80NA
Q3 2022
11/14/2022
1.24-0.29-1.16NA
Q2 2022
8/9/2022
2.64-0.25-1.00NA
Q1 2022
5/11/2022
2.50-0.17-0.68NA
Q4 2021
3/30/2022
2.66-11.74-46.96NA
Q3 2021
11/18/2021
10.71-8.12-32.48NA
Quotes delayed 20 minutes

Email EnvelopeFree CGTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cognition Therapeutics (CGTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CHE PE Ratio History
CHMA PE Ratio History
CHRS PE Ratio History
CI PE Ratio History
CINC PE Ratio History
CKPT PE Ratio History
CLBS PE Ratio History
CLDX PE Ratio History
CLNN PE Ratio History
CLOV PE Ratio History
On this page we presented the CGTX PE Ratio History information for Cognition Therapeutics' stock. The average CGTX PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CGTX PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CGTX PE ratio history result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for CGTX had been 1.86, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CGTX or any other given stock, valuation analysis for CGTX can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cognition Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for CGTX. Thanks for visiting, and the next time you need to research CGTX PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: NVR market cap history, FOCS Insider Buying, WFD Split History.

 

CGTX PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.